Bill 112: Access to PrEP Act

This bill primarily affects pharmacies and pharmaceutical benefit managers operating in Nova Scotia, as they will be required to dispense PrEP medications as a covered benefit without collecting copayments from patients. Pharmacies — from independent community drugstores to larger chain locations — will need to update their billing and point-of-sale processes to reflect the zero-copayment status for these specific antiviral drugs. Healthcare clinics and prescribers, particularly sexual health clinics, will also see administrative changes as PrEP becomes more accessible. The impact falls mainly on any pharmacy or dispensing operation doing business under the Nova Scotia provincial drug benefit program, regardless of size.